Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew help and navigation sections and contact information were added to guide users through eligibility and joining the study. The Intervention/Treatment heading was introduced/normalized and the older Intervention / Treatment heading was removed, with the revision stamp updated to v3.6.0.SummaryDifference0.4%

- Check18 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a new version of the page. This is an informational update and does not change the study content or on-page data.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's revision label updated from v3.5.3 to v3.5.4, reflecting a new software version. No study content appears to be affected by this change.SummaryDifference0.0%

- Check54 days agoChange DetectedThe Taiwan recruitment site label was changed from Taoyuan to Taoyuan City, Taiwan, 33308, clarifying the exact city designation for this location. This update improves the accuracy of the study's geographic information as presented in the record.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site update rather than any change to the study information.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.5.2 has been added. Revision: v3.5.0 has been removed.SummaryDifference0.0%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.